Comparison of radionuclide myocardial perfusion/metabolic imaging with cardiac magnetic resonance for assessment of myocardial viability: current status and progress
10.3760/cma.j.cn321828-20230106-00003
- VernacularTitle:核素心肌灌注/代谢显像与心脏MR成像评价心肌活力的研究现状及进展
- Author:
Shuyang SONG
1
;
Lei WANG
;
Wei FANG
Author Information
1. 北京协和医学院、中国医学科学院阜外医院核医学科，北京 100037
- Keywords:
Myocardium;
Myocardial perfusion imaging;
Positron-emission tomography;
Fluorodeoxyglucose F18;
Magnetic resonance imaging;
Trends
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2024;44(5):317-320
- CountryChina
- Language:Chinese
-
Abstract:
Radionuclide myocardial perfusion/metabolic imaging and cardiac MR play critical roles in assessing myocardial viability of patients with ischemic heart disease as noninvasive modalities. Given the technical difference between two imaging modalities, each of them has its unique strength to ascertain what causes the injured myocardium and differentiate the viable myocardium from the scarred myocardium. The purpose of this review is to compare the capability of two methods in assessment of myocardial viability, including summarize their consistency and discrepancy, as well as to explore the clinical significance to combine them serving as an essential tool to assist decision making for coronary revascularization comprehensively and accurately.
